ABSTRACT: To achieve biological regeneration of tendon-bone junctions, cell sheets of human rotator-cuff derived cells were used in a rat rotator cuff injury model. Human rotator-cuff derived cells were isolated, and cell sheets were made using temperature-responsive culture plates. Infraspinatus tendons in immunodeficient rats were resected bilaterally at the enthesis. In right shoulders, infraspinatus tendons were repaired by the transosseous method and covered with the cell sheet (sheet group), whereas the left infraspinatus tendons were repaired in the same way without the cell sheet (control group). Histological examinations (safranin-O and fast green staining, isolectin B4, type II collagen, and human-specific CD31) and mRNA expression (vascular endothelial growth factor; VEGF, type II collagen; Col2, and tenomodulin; TeM) were analyzed 4 weeks after surgery. Biomechanical tests were performed at 8 weeks. In the sheet group, proteoglycan at the enthesis with more type II collagen and isolectin B4 positive cells were seen compared with in the control group. Human specific CD31-positive cells were detected only in the sheet group. VEGF and Col2 gene expressions were higher and TeM gene expression was lower in the sheet group than in the control group. In mechanical testing, the sheet group showed a significantly higher ultimate failure load than the control group at 8 weeks. Our results indicated that the rotator-cuff derived cell sheet could promote cartilage regeneration and angiogenesis at the enthesis, with superior mechanical strength compared with the control. Treatment for rotator cuff injury using cell sheets could be a promising strategy for enthesis of tendon tissue engineering. ß 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:289-296, 2017.
Rotator cuff tears affect 40% or more of patients older than 60 years and are a common cause of debilitating pain, reduced shoulder function, and muscle weakness. 1 Open and arthroscopic rotator cuff repair have achieved good results with respect to functional outcome and pain relief. 2, 3 Despite continuing advances in surgical repair techniques and modifications to postoperative rehabilitation strategies, magnetic resonance imaging and ultrasonography studies continue to reveal that 10-70% of rotator cuff repairs go on to form a recurrent tendon re-tear after surgery. [4] [5] [6] Recently, attention has shifted from biomechanical aspects to biological tendon healing to improve tendonto-bone healing for better surgical outcomes in rotator cuff research. Several authors have reported improved healing of tendon-bone junctions using tissue engineering techniques such as stem cells, 7 growth factors, 8 scaffolds, 9, 10 and platelet-rich plasma. 11, 12 Recently, cell sheet technology has been developed as an alternative method of cell delivery. [13] [14] [15] The engineered cell sheets showed preserved cellular communication, junctions, endogenous extracellular matrix, and integrative adhesive agents. 16 Lui et al. 17 reported that cell sheets composed of tendon-derived stem cells improved early graft healing after anterior cruciate ligament reconstruction in a rat model. Regarding rotator cuff-derived cells, Utsunomiya et al. 18 reported that the cells from human shoulder tissue (synovium of the glenohumeral joint, subacromial bursa, margin of the ruptured supraspinatus tendon, and residual tendon stump on the greater tuberosity) have a potential of self-proliferation and multilineage differentiation in vitro. We assumed that rotator cuffderived cells have a similar potential in vivo, as suggested by Utsunomiya et al. Moreover, Tsai et al. 19 suggested that human rotator cuff mesenchymal stem cells (MSCs) could be another cell source for cell therapies in patients with tendon and muscle injury, or with dystrophic muscle disorders. The use of cell sheets composed of rotator cuff-derived cells has not yet been studied. We hypothesized that the cell sheet developed by rotator cuff-derived cells could enhance the regeneration of the bone-tendon junction. The aim of this study was to investigate the efficacy of cell sheets composed of human rotator cuff-derived cells in a rat rotator cuff tear model.
MATERIALS AND METHODS

Preparation of Human Rotator Cuff-Derived Cells
Human rotator cuff-derived cells were isolated from the torn edges of human supraspinatus tendons, which were obtained during arthroscopic rotator cuff repair with informed consent from the patients (two men aged 66 and 55 years, and one woman aged 75 years). The tissues (weighing approximately 0.3 g each) were cut into small pieces under sterile conditions, followed by digestion in Dulbecco's modified Eagle's medium (DMEM) (Sigma-Aldrich, St. Louis, MO) supplemented with 30 mg/ml collagenase II (Life Technologies, Carlsbad, CA) at 37˚C, 95% humidity, and 5% CO 2 . After digestion, the cells were pelleted, washed in phosphatebuffered saline (WAKO, Tokyo, Japan), and subsequently cultured in 75 cm 2 cell culture flasks with DMEM supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich) and 1% penicillin-streptomycin (PS) (Sigma-Aldrich). All experiments were performed with cells passaged once or twice, and the same passage of cells was used for each experiment.
Previously, we assessed the character of rotator cuff derived cells. 20 The cells could be cultured for at least 10 passages and 14.2 AE 0.4 population doublings (range, 13.8-15.0), showing neither a change in morphology nor a reduction in proliferation. In addition, the cells have multilineage potential to differentiate to chondrocyte under TGFb3 and BMP6 as MSCs. On flow cytometric analyses, MSC-related markers CD29, CD44, CD105, and CD166 were positive in the cells from the torn human rotator cuff. These data provided rotator cuff derived cells have stable character and are suitable for use in our experiments, though the data could not be shown in this article.
Cell Sheet Preparation
To characterize the cells, the isolated rotator cuffderived cells were first incubated with 1,1 0 -dioctadecyl-3,3,3 0 ,3 0 -tetramethylindocarbocyanine (DiI) (Molecular Probes, Eugene, OR) for 20 min. After washing, 5 Â 10 5 cells per well were incubated on the 24-well temperature-responsive culture plate (UpCell TM ; CellSeed, Tokyo, Japan) in DMEM (Sigma-Aldrich) supplemented with 10% FBS (SigmaAldrich) and 1% PS (regular medium) (Sigma-Aldrich) at 37˚C for 17 h. Then, the plate was incubated at room temperature for 20 min. During that time, the cell sheets detached from the well as free-floating monolayers. The cell sheet was the size of the well of 24 wells plate. The diameter was about 1 cm (0.4 in, Fig. 1a ). The sterile procedure was observed strictly during an all preparation and operation.
The each cell sheet was consisted of only one donor cells and use at randomly in the operation described below.
Animal Model of Rotator Cuff Repair
A rat model based on previous studies 21, 22 was used because of anatomical similarity in the shoulder between rats and humans. The approval was obtained from the Institutional Animal Care and Use Committee. Thirty 12-week-old immunodeficient rats (F344/NJCl-rnu rnu/rnu), with a mean weight of 250 g, were used in present study (CLEA Japan, Inc., Tokyo, Japan).
All operations were performed by one surgeon (author) under sterile conditions and anesthesia with isoflurane (Wako), intraperitoneal injection of pentobarbital sodium (50 mg/kg; Kyoritsu Seiyaku, Tokyo, Japan), and subcutaneous injection of lidocaine (2.5 mg/kg, Xylocaine 1 ; AstraZeneca, London, UK) at the surgical site. The animals were placed in a lateral position, and a 1 cm incision was made over the lateral border of the acromion. A small portion of the deltoid muscle was divided to expose the underlying acromion and the infraspinatus tendon. To visualize the rotator cuff, the acromioclavicular joint was divided. The infraspinatus tendon was carefully identified and cut off at the insertion to the greater tuberosity. The footprint was abraded to remove normal enthesis. In the right shoulders, tendons were repaired by a transosseous technique using 4-0 nylon suture, and the repaired site was covered with the cell sheet (sheet group, n ¼ 30, Fig. 1b) . The cell sheet was secured by the nylon suture between the repaired site and suture as shown in Figure 1c . In the left shoulders, the tendons were repaired in the same way without coverage of the cell sheets (control group, n ¼ 30). The deltoid split and skin were closed with 4-0 nylon. The enthesis of rat infraspinatus was easier to operate compared with supraspinatus because of the rat's position under the operation. After the operation, all rats were immediately allowed to move freely within their each cage in laminar flow rack. Rats were euthanized with overdose of isoflurane and intraperitoneal injection of pentobarbital sodium at the indicated times.
Histological Examination
To analyze the localization of the cell sheets, six rats were euthanized 1 week after transplantation of the cell sheets stained by only DiI. The scapular-humeral complexes were harvested and quickly embedded in Optimal Cutting Temperature (OCT) compound (Sakura Finetek USA, Inc., Torrance, CA), and stored at À80˚C for histochemical and immunohistochemical staining as described below. The scapula-humeral complex with the infraspinatus muscle in the OCT blocks was sectioned serially with a thickness of 6 mm, mounted on a silane-coated glass slide, and air-dried for 1 h before fixation with 4% paraformaldehyde at 4˚C for 5 min. 4 0 ,6-diamidino-2-phenylindole (DAPI) solution was applied for 5 min for nuclear staining. All sections were visualized on a fluorescence microscope (BZ-8000 confocal microscope; Keyence, Osaka, Japan). The number of positively stained cells was counted in five randomly selected fields (250 Â 250 mm) at the repaired site.
For safranin-O and fast green staining, the sections were stained with hematoxylin for 10 min, followed by fast green stain for 5 min and safranin-O for 5 min. In immunofluorescence staining, isolectin B4-antibody (Vector Laboratories, Burlingame, CA), which is a rat-specific endothelial marker, was used to access the regenerated capillaries and/or neovascularity. 23 Type II collagen (Col2) antibody (Cosmo Bio, Tokyo, Japan) was used to assess fibrocartilage regeneration. To detect differentiated human cells at the grafted tendon sites and/or the interface zone between bone and tendon in the rats, immunohistochemistry was performed at week 4 with human-specific CD31 (hCD31) antibody (eBioscience, San Diego, CA). 24 All antibodies were conjugated with fluorescein isothiocyanate (FITC). Isolectin B4, Col2, and hCD31 antibodies were used at a 1:100 dilution, and staining was performed at room temperature for 1 h. DAPI solution was applied for 5 min for nuclear staining. After staining, we evaluated the number of positively stained cells in five randomly selected fields.
Quantitative Real-Time Polymerase Chain Reaction
We examined real-time polymerase chain reaction (PCR) to reveal the gene expression related regeneration of tendonbone junction at 4 weeks after the surgery (n ¼ 6 in each shoulder). The enthesis of the infraspinatus tendon was excised in 2 mm width and depth. Thereafter, the total RNA was extracted using an RNeasy Mini Kit (QIAGEN, Valencia, CA) according to the manufacturer's protocol. Oligo (deoxythymidine)-primed first-strand cDNA was synthesized using a High Capacity cDNA Transcription Kit (Applied Biosystems, Foster City, CA). Quantitative real-time PCR was performed in a 20 ml reaction mixture using the SYBR Green Master Mix reagent (Applied Biosystems) on the ABI prism 7500 sequence detection system (Applied Biosystems). The PCR conditions were as follows: 1 cycle at 95˚C for 10 min followed by 40 cycles at 95˚C for 15 s, and 60˚C for 1 min. The mRNA expressions of type II collagen (Col2), vascular endothelial growth factor (VEGF), and tenomodulin (TeM) were analyzed.
The primer sequences were as follows: 0 -GGATGACCTTGCCCACAGCC-3 0 . The relative expressions of the genes were calculated using the DD -Ct method, normalizing to GAPDH.
Biomechanical Testing
Eight weeks after surgery, 12 rats were euthanized, and shoulders were biomechanically tested. Before the biomechanical tests, all soft tissue except the infraspinatus tendon-humeral complex was carefully removed. The prepared infraspinatus-humeral complex was mounted in a conventional tensile tester (model AGIS 5kN; Shimadzu, Kyoto, Japan). The humerus was embedded in an aluminum tube with use of polymethylmethacrylate. Testing was performed with the shoulder at 60˚of abduction in a materials testing machine. The humerus was clamped with its long axis in the horizontal plane. The proximal end of the infraspinatus tendon was glued between two pieces of sandpaper. The sandpaper-tendon complex was clamped vertically. The biomechanical testing protocol that we used was similar to that described by Galatz et al. 25 and Mikolyzk et al. 26 Specimens were subjected to a preload of 0.2 N and were preconditioned for five cycles to 0.38 mm of displacement (approximately 5% of gauge length at a rate of 0.1 mm/s). A stress relaxation test was then performed for 300 s at 0.38 mm of displacement followed by 300 s of recovery. Specimens were then tested to failure in tension at a rate of 0.1 mm/s. The ultimate failure load was determined for each specimen.
Statistical Analysis
The power analysis of this study was based on a previous study that evaluated shoulder enthesis healing in Lewis rats. 27 A power of 0.80 is achieved using 12 shoulders with a ¼ 0.05 for biomechanical testing. All data are expressed as mean values AE standard deviations. The Mann-Whitney U test was used to compare two groups. Results with p-value <0.05 were considered significant. The data were analyzed using SPSS ( 
RESULTS
Histological Examination
To analyze the localization of the cell sheets, six rats were euthanized 1 week after transplantation of the cell sheets. Bright field image is Figure 2a . The cell sheet stained by DiI is seen in the white dotted circle in Figure 2b . The cell sheet was seen at the enthesis in the sheet group (Fig. 2c) .
In the sheet group, strong proteoglycan staining was observed at the repaired enthesis at 4 weeks postoperatively with safranin O and fast green staining ( Fig. 3a and b) , whereas less staining was observed in the control group ( Fig. 3c and d) . In the control group, the scar tissue was showed around the tendon fiber. The scar tissue well observed at repaired shoulder without cell sheet compared with repaired shoulder by cell sheet.
Immunofluorescence Staining
Angiogenesis at the rotator cuff repaired site was detected by immunofluorescence staining of endothelial markers. At 4 weeks after surgery, vascular staining with isolectin B4 demonstrated an enhancement of intrinsic neovascularization around the repaired site in the sheet group (Fig. 4d ) compared with that in the control group (Fig. 4a) (Fig. 4g) . Immunofluorescence staining of Col2 demonstrated an enhanced healing process of the bone-tendon junction in the sheet group. The number of Col2-positive cells was significantly greater in the sheet group (Fig. 4e ) than in the control group (Fig. 4b) (Fig. 4h) . Immunofluorescence staining of hCD31 demonstrated an 
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enhanced differentiation and migration process of human-derived cells. In the sheet group, considerable hCD31-positive cells were confirmed at week 4 ( Fig. 4f ). There were no hCD31-positive cells in the control group (Fig. 4c) . The hCD31 was stained at only tendon-bone junction in the shoulders repaired with cell sheets. On the other hand, there was no staining at the control shoulder.
Quantitative Real-Time PCR Figure 5 shows the gene expression of VEGF, Col2, and TeM in the repaired enthesis. VEGF and Col2 expressions in the sheet group were higher than those in the control group (p < 0.05 for sheet vs. control), whereas TeM expression in the sheet group was lower (p < 0.05 for sheet vs. control) than that in the control group.
Biomechanical Testing
In the mechanical testing at week 8, the sheet group showed a significantly higher ultimate failure load than the control group (sheet, 26.8 AE 4.4 N; control, 16.6 AE 8.6 N, p < 0.05 for sheet vs. control) (Fig. 6) . In all cases, the sample was broken at the tendon-bone junction during the mechanical testing. 
DISCUSSION
Scaffolds, growth factors, and stem cells are essential components of rotator cuff tissue engineering. The cell delivery method is another important issue, and several methods have been reported. Yokoya et al. 28 created an infraspinatus defect in a rabbit model and embedded a polyglycolic acid (PLGA) sheet with MSCs in the defect site. They reported that the sheet enhanced the expression of type I collagen products and increased the mechanical strength of the regenerated tendon in vivo. Other articles reported that a fibrin glue carrier seeded with MSCs 26 or tendonderived stem cells 29 could promote earlier and better recovery after the tendon injury.
The tissue-engineered contractile cell sheet technique is considered to be a very promising method for enhancing angiogenesis and osteogenesis. [30] [31] [32] [33] [34] Memon et al. 35 reported that autologous skeletal myoblast cell transplantation, via direct injection, was subject to a loss of intercellular communication, extracellular matrix, and cell numbers. Kondoh et al. 16 reported that a myoblast cell sheet graft was superior to direct cell injection for improving cardiac performance in dilated cardiomyopathy. Sekiya et al. 36 demonstrated that cell sheets comprising muscle-derived stem cells were superior to direct cell injection for treating the hearts of mice that had undergone acute myocardial infarction. Regarding tendon tissue engineering, Mifune et al. 37 showed tendon grafts wrapped in cell sheets composed of anterior cruciate ligament-derived CD34-positive cells could enhance the healing of the tendon-bone junction by promoting increased proprioceptive recovery, graft maturation, and biomechanical strength in a rat model of anterior cruciate ligament reconstruction. Furthermore, this technique was recently used for the treatment of cartilage damage. 38, 39 Hamahashi et al. 40 suggested that the humoral factors produced by layered chondrocyte sheets may contribute to cartilaginous tissue repair and regeneration. In the current study, we applied this cell sheet technology to rotator cuff repair surgery and demonstrated that tendon-bone junction repair using rotator cuff-derived cell sheets was as efficient as other techniques previously described [27] [28] [29] for rotator cuff repair. Gulotta et al. reported the rat supraspinatus repair with adenoviral MT1-MMP (Ad-MT1-MMP)-transduced MSCs in a fibrin glue carrier. 27 The ultimate load to failure at post 41 reported that the cells harvested from human subacromial bursa showed a new source of MSCs with a high potential for application in tendon repair. We demonstrated, using real-time PCR and immunofluorescence staining that the transplanted rotator cuff-derived cells promote tendon-bone junction healing by synthesis of Col2 and VEGF and selfdifferentiation to vascular endothelial cells. This result indicated that rotator cuff-derived cells have the ability to promote angiogenesis. We found that the transplanted cells survived at least 1 week at the repair site, and the cells were differentiated to hCD31-positive cells at 4 weeks. The hCD31 is human specific antigen, and they could not be detected before transplantation in rat. This result suggested that the human rotator cuff-derived cells were differentiated to human vascular endothelial cells in a rat model, and promoted angiogenesis by a paracrine system of cytokines such as VEGF. Previous report showed the bone marrow-derived mesenchymal stem cells produce an array of angiogenesis-related proteins, and support angiogenesis in vitro via a paracrine mechanism. However, when these cells are differentiated chondrogenically or osteogenically, they produce a soluble factor that inhibits angiogenesis. 42 In our study, the anti-angiogenesis effect has not detected.
Our histological examination using safranin-O and fast green staining showed strong proteoglycan staining at the enthesis in the sheet group, whereas less staining was observed in the control group. Mechanical testing showed that the ultimate failure load in the repaired group with the cell sheet was greater than that in the control group at 8 weeks after surgery. Leung et al. 43 reported that the formation of the new bone and cartilage at the healing process was associated with the strength of the reattachment between bone and tendon. We showed scar tissue and less proteoglycan staining at the repair site in the control shoulders. Proteoglycan is cartilage matrix produced by chondrocyte. The increase of proteoglycan at the repaired enthesis involved an increase of chondrocyte at the enthesis. We speculate that the cell sheet enhanced fibrocartilage regeneration at the enthesis, which led to superior mechanical strength compared with that in the control shoulders.
Our real-time PCR results showed that TeM expression was significantly lower in the sheet group than in the control shoulders. TeM is a type II transmembrane glycoprotein that contains a C-terminal domain with homology to the mature, secreted form of chondromodulin-I, a cartilage-derived angiogenesis inhibitor. 44 Angiogenesis is one of the most fundamental factors needed for repairing the tendon-bone junction. 45, 46 We showed that higher gene expression of VEGF played a central role in promoting angiogenesis in the sheet group compared with that in the control group. This result indicated that the cell sheet engineered with rotator cuff-derived cells suppressed TeM expression and promoted VEGF expression and angiogenesis, thus promoting chondral tissue synthesis at the enthesis.
We have to discuss how to use transplantation of cell sheet in the clinical situation. Wang A reported that PRP treatment did not improve early functional recovery, range of motion, or strength or influence pain scores at any time point after arthroscopic supraspinatus repair. 47 The cell sheet transplantation has a merit about transplantation efficiency in comparison to the cell injection 37 ; however, cell culture and preparation of cell sheet demand at least 2 weeks. We suggested that the pragmatic procedure of cell sheet transplantation for human shoulder is an extraction under echo guiding prior to the rotator cuff repair operation.
Some limitations of our study should be noted. First, the rotator cuff-derived cells were harvested from the torn human rotator cuffs. This means the cells we used in this study might have degenerative potential that could negatively affect the regeneration potential of the tendon and enthesis. Owing to ethical problems, we did not harvest human tissue from intact rotator cuffs, but cell sources should be optimized in future studies. 18 Second, in quantitative real-time PCR, it was difficult to obtain only enthesis from the rat's shoulder because the size was too small. Therefore, the tendon and bone at immediately above and below the enthesis were contained in the tissue. This means the result of quantitative real-time PCR showed gene expression about not only the enthesis but also the imperceptible tissue of tendon and bone. However, all tissues harvested for PCR were same size and contained tendon, enthesis, and bone equally. We considered the results of quantitative real-time were appropriate for assessment. Third, because rats have a greater healing capacity than humans, the tendonbone healing process in rats progresses at a faster rate than that in humans. A large-animal model with longer and more frequent testing time points is warranted for examining the effectiveness of cell sheet transplantation for rotator cuff repair in humans. Fourth, the cell sheet was transplanted to SAB side of repaired enthesis because this treatment procedure was estimated like an augmentation for massive tear of rotator cuff. We had no examination that the cell sheet was transplanted to another site such as between edge of tendon and abraded footprint. Further study will be needed to prove the best position for cell sheet transplantation. In conclusion, this is a first study demonstrating the proof of concept about engineered cell sheets using human rotator cuff-derived cells. The human rotator cuff-derived cells have a potency and paracrine ability to promote angiogenesis and regeneration of cartilage tissue. The cell sheets transplanted to the repaired site of the infraspinatus induced angiogenesis and collagen synthesis, and the tendon-bone junction was well repaired after transplantation in an immunodeficient rat model.
